CARLSBAD, Calif.—In een recente transactie heeft Brett P. Monia, Chief Executive Officer van Ionis Pharmaceuticals Inc. (NASDAQ:IONS), 140 aandelen van het gewone aandelenkapitaal van het bedrijf verk ...
Woensdag handhaafden analisten van Oppenheimer hun Outperform-rating voor Ionis Pharmaceuticals (NASDAQ:IONS) met een stabiel koersdoel van $ 78,00. Het aandeel, dat momenteel op $ 33,03 noteert, ligt ...
"Angelman Syndrome is a neurogenetic disorder," said Weston's mother Felicia Warner. "It affects a lot of different things. It affects their balance, a very high percentage has seizures ...
Ionis has committed to a phase 3 programme for its antisense therapy for rare genetic disorder Angelman syndrome, just weeks after Biogen decided against exercising an option to license the drug.
Cushing syndrome occurs due to abnormally high levels of cortisol, which is commonly related to steroid use. Symptoms include weight gain, thinning skin, fluid retention, and stretch marks, among ...
ROCKY RIVER, Ohio — In September, I introduced you to the Synk family. Their 3-year-old daughter, Immy, has Angelman Syndrome. It is a rare neurogenetic disorder that affects about one in 15,000 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results